Search

Your search keyword '"Dyer, Martin J. S."' showing total 42 results

Search Constraints

Start Over You searched for: Author "Dyer, Martin J. S." Remove constraint Author: "Dyer, Martin J. S." Publisher american society of hematology Remove constraint Publisher: american society of hematology
42 results on '"Dyer, Martin J. S."'

Search Results

1. Venetoclax retreatment of patients with chronic lymphocytic leukemia after a previous venetoclax-based regimen

2. Dual dependence on BCL2 and MCL1 in T-cell prolymphocytic leukemia

3. Phase 1b study of venetoclax-obinutuzumab in previously untreated and relapsed/refractory chronic lymphocytic leukemia

4. Long-term follow-up of patients with CLL treated with the selective Bruton’s tyrosine kinase inhibitor ONO/GS-4059

5. Ibrutinib efficacy and tolerability in patients with relapsed chronic lymphocytic leukemia following allogeneic HCT

6. Germ line mutations in shelterin complex genes are associated with familial chronic lymphocytic leukemia

7. BRAF inhibition in hairy cell leukemia with low-dose vemurafenib

8. A phase 1 clinical trial of the selective BTK inhibitor ONO/GS-4059 in relapsed and refractory mature B-cell malignancies

9. Recurrent CDKN1B (p27) mutations in hairy cell leukemia

10. t(X;14)(p11;q32) in MALT lymphoma involving GPR34 reveals a role for GPR34 in tumor cell growth

11. Common variation at 6p21.31 (BAK1) influences the risk of chronic lymphocytic leukemia

13. The PARP inhibitor olaparib induces significant killing of ATM-deficient lymphoid tumor cells in vitro and in vivo

14. Deregulation of the telomerase reverse transcriptase (TERT) gene by chromosomal translocations in B-cell malignancies

15. Presence of the P2RY8-CRLF2 rearrangement is associated with a poor prognosis in non–high-risk precursor B-cell acute lymphoblastic leukemia in children treated according to the ALL-BFM 2000 protocol

16. Increasing the efficacy of CD20 antibody therapy through the engineering of a new type II anti-CD20 antibody with enhanced direct and immune effector cell–mediated B-cell cytotoxicity

17. Immunoglobulin heavy chain locus chromosomal translocations in B-cell precursor acute lymphoblastic leukemia: rare clinical curios or potent genetic drivers?

19. Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia

21. Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival

22. p73, miR106b, miR34a, and Itch in chronic lymphocytic leukemia

24. Insight into the pathogenesis of chronic lymphocytic leukemia (CLL) through analysis of IgVH gene usage and mutation status in familial CLL

27. t(6;14)(p22;q32): a new recurrent IGH@ translocation involving ID4 in B-cell precursor acute lymphoblastic leukemia (BCP-ALL)

28. A high-density SNP genome-wide linkage search of 206 families identifies susceptibility loci for chronic lymphocytic leukemia

29. Five members of the CEBP transcription factor family are targeted by recurrent IGH translocations in B-cell precursor acute lymphoblastic leukemia (BCP-ALL)

30. Homozygous deletions localize novel tumor suppressor genes in B-cell lymphomas

32. Transformation of follicular lymphoma to diffuse large cell lymphoma is associated with a heterogeneous set of DNA copy number and gene expression alterations

34. Recurrent involvement of the REL and BCL11Aloci in classical Hodgkin lymphoma

35. The BCL11 gene family: involvement of BCL11A in lymphoid malignancies

36. Loss of a novel tumor suppressor gene locus at chromosome 8p is associated with leukemic mantle cell lymphoma

37. Cyclin D3 is a target gene of t(6;14)(p21.1;q32.3) of mature B-cell malignancies

38. High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H

40. BCL10 gene mutation in lymphoma

41. BCL2/BCL-XL inhibition induces apoptosis, disrupts cellular calcium homeostasis, and prevents platelet activation.

Catalog

Books, media, physical & digital resources